Deep learning with Convolutional Neural Networks has shown great promise in various areas of image-based classification and enhancement but is often unsuitable for predictive modeling involving non-image based features or features without spatial correlations. We present a novel approach for representation of high dimensional feature vector in a compact image form, termed REFINED (REpresentation of Features as Images with NEighborhood Dependencies), that is conducible for convolutional neural network based deep learning. We consider the correlations between features to generate a compact representation of the features in the form of a two-dimensional image using minimization of pairwise distances similar to multi-dimensional scaling. We hypothesize that this approach enables embedded feature selection and integrated with Convolutional Neural Network based Deep Learning can produce more accurate predictions as compared to Artificial Neural Networks, Random Forests and Support Vector Regression. We illustrate the superior predictive performance of the proposed representation, as compared to existing approaches, using synthetic datasets, cell line efficacy prediction based on drug chemical descriptors for NCI60 dataset and drug sensitivity prediction based on transcriptomic data and chemical descriptors using GDSC dataset. Results illustrated on both synthetic and biological datasets shows the higher prediction accuracy of the proposed framework as compared to existing methodologies while maintaining desirable properties in terms of bias and feature extraction.
Introduction
In recent years, machine learning has been able to produce numerous insights from the surge of data generated in diverse areas. For instance, the area of computational biology has benefitted from the availability of high throughput information for genome, transcriptome, proteome and metabolome. These large datasets often have the issue of numerous features with limited samples which necessiates the use of feature selection or feature extraction prior to modeling. A predictive modeling framework that has high accuracy and incorporates inbuilt feature extraction or selection can be highly useful in such circumstances. In pharmacogenomics studies, in order to predict drug efficacy, based on genomic characterizations, various types of machine learning approaches such as Random Forests, Elastic Net, Kernelized Bayesian Multi Task learning, Support vector Regression have been proposed [1, 2, 3, 4] where an initial step of feature selection or extraction has been included before model building.Although, sparse linear regression approaches such as Lasso and Elastic Net do offer embedded feature selection but the accuracy of the models are significantly lower than ensemble, kernel and non-linear regression approaches under model misspecification [1] . On the other hand, deep convolutional neural networks (CNN) has the potential to provide high accuracy prediction while automatically discovering multiple levels of joint representation of the data and thus eliminating the need for feature engineering or selection [5] . CNN bypasses the a priori manual extraction of features by learning them from data [6] . Furthermore, their representational richness often allows capturing of nonlinear dependencies at multiple scales [7] , and minimizing generalization error rather than the training error [8] .
CNN based Deep Learning methods have shown improved performance in speech recognition, object recognition [9] , natural language processing [10] , genomics [11] and cancer therapy [12] . Deep (multi-layered) neural networks are especially well-suited for learning representations of data that are hierarchical in nature, such as images or videos [15] . CNN-based methods have achieved close to human-level performance in object classification, where a CNN learns to classify the object contained in an image [16] . In the computational biology area, Alipanahi et al [11] used 1-D CNN architecture to predict specificities of DNA and RNA binding proteins by directly training on the raw DNA sequence. Note that 1-D CNN can be directly applied to scenarios where the features have relationships with neighbors such as DNA or RNA sequences. However, a 1-D CNN will not be highly effective in scenarios where ordering of features does not describe the dependencies among features. For instance, gene expressions or chemical descriptors, in their raw form, do not exhibit any form of ordering and hence not amenable to 1-D CNN.
If, on the other hand, the predictors are in form of images, a CNN model is often effective because the spatial correlation among the neighbors can be exploited to reduce the number of model parameters compared to fully connected network by applying convolutional operations and sharing parameters. In classification setup, [12] demonstrated the efficiency of this approach to distinguish the most prevalent subtype of lung tumor from normal lung tissue using whole slide images of The Cancer Genome Atlas (TCGA) dataset and validating on independent histopathology images. Thus, the ability to represent a collection of potentially high dimensional scalar features as images, with correlated neighborhoods, has the potential of benefiting from the automated feature extraction and high accuracy predictions of CNN based Deep Learning. To our knowledge, the only other approach for representing data as images is OmicsMapNet [13] that has been proposed at the same time while we were developing our REFINED idea. OmicsMapNet uses treemap [14] to rearrange omics data into 2D images which requires preliminarily knowledge extracted from KEGG. OmicsMapNet cannot be used when there is no ontology knowledge on the omics data, or when the covariates are non-omics data such as drug descriptors.
In this paper, we present a novel methodology, termed REFINED (REpresentation of Features as Images with NEighborhood Dependencies), for representing high dimensional feature vectors as mathematically justifiable 2D Images that can be processed by standard convolutional neural network based deep learning methodologies. We illustrate the advantages of our proposed framework in terms of accuracy and bias characteristics on both synthetic and biological datasets.
Materials and Methods
In this section we introduce our proposed REFINED algorithm that maps high-dimensional feature vectors to images, describe the datasets used for performance evaluation, followed by the CNN architecture used as the predictive model.
REpresentation of Features as Images using NEighborhood Dependencies (REFINED)
As mentioned earlier, the main idea of the REFINED CNN approach is to map highdimensional vectors to mathematically justifiable images for training by traditional CNN architecture. Evidently, a mapping of features from the high dimensional vector to a 2-D image matrix serially in a row by row or column by column fashion will not guarantee any spatial correlations in the image. Instead, we first obtain the euclidean distance matrix of the features and use it as a similarity measure to generate a compact 2D feature representation where neighborhood features are closely related. A potential solution to achieve this 2-D projection is to apply dimensionality reduction approach such as Multidimensional Scaling (MDS) [20] on a distance measure such as euclidean distance of features. However, that will not guarantee that each mapped point will have a unique voxel representation in the image and might result in sparse images due to the overlap [21] . For instance, if we have 900 features, the features can potentially be represented by a 30 × 30 matrix and a direct MDS like approach on a 30 × 30 dimension space might not spread out each feature in such a manner that each voxel contains only one feature. To ensure that the features are spaced out in a discrete grid and to incorporate the discrete nature of the image voxels, we apply a Bayesian version of metric MDS. We start with the MDS algorithm to create an initial feature map (a 2-D space with feature coordinates) that preserves the feature distances in the 2-D space with minor computational cost. Next, we apply the Bayesian MDS (BMDS) to estimate the feature location on a bounded domain with the constraint that each voxel can at most contain one feature. However, the location of the features are estimated up to an automorphism. Therefore, we apply a hill climbing algorithm, with a cost function that measures the absolute difference in the Euclidean distances among the new feature locations (as represented by the 2D image map) to the estimated true distances (δ δ δ , anticipating the following section) among the features, to arrive at an optimal configuration. More specifically, starting from the BMDS location estimates, we considered all the configurations in the map sequentially in row-order. For each feature, we tried different permutations of the features by interchanging the position of the central feature position with its neighboring features and selected the permutation that minimizes the above mentioned cost function. The general idea of the REFINED CNN approach is shown pictorially in Figure 1 for the application case of predicting drug efficacy over a cell line using chemical descriptors of the drug as predictors. 1 In Figure 1 , an example case is shown where F-12 has been interchanged with its neighboring features, and after each exchange, we have checked the similarities/correlation among distances of features from the map and estimated distance matrix of descriptors. If we can find a better exchange case in the feature map, we exchange that feature pair and arrive at a new feature map. The entire process was repeated iteratively until we reached the optimized feature map that is close to the benchmark distance matrix (δ δ δ ) of the initial features (in this case PaDEL descriptors).
At the conclusion of this iterative algorithm, we arrive at a REFINED feature map with all features having a unique position in a bounded 2-D space and similar features are placed close by and dissimilar features are far apart. Without loss of generality, we have considered feature maps on unit square and the BMDS specification induced sparsity in the image. Figure 2 shows some generated REFINED images for different drugs. Each image varies from another depending on the value of the PaDEL descriptors of the drug, but the descriptor coordinates are same for all the cases.
Theoretical Basis for REFINED
Consider the predictor matrix X X X = {x i j }, i = 1, 2, ..., n; j = 1, 2, ..., p with x i j being the value of the jth predictor for the ith subject. Suppose, the predictors are generated from a latent zero mean, square integrable stochastic process {Z(s)} where the index s belongs to a compact subset of R m . Let s j denote the original position of the jth predictor produced by Z(s) and the observed data is randomly permuted version of the original data, i.e. x i j = Z i (s j ).
Case 1: There is a underlying true ordering of the predictors , i.e., there exists a permutation {π(1), ..., π(p)} of {1, 2, ..., p} such that s π(1) < s π(2) < ... < s π(p) is the true, but unknown, ordering of the predictors. If such ordering exists, we can take m = 1 and the predictors can be projected on [0, 1] via unidimensional scaling (UDS). Let {ŝ 1 , ...,ŝ p } be the estimated locations of the p predictors on [0, 1] obtained via UDS. Let {ψ(1), ..., ψ(p)} be the permutation of {1, 2, ..., p} that orders {ŝ 1 , ...,ŝ p }. Then under some regularity conditions ψ( j) = π( j), 1 ≤ j ≤ p, ∀p. Thus UDS can correctly identify the true relative pairwise distances among the predictors.
For proof, see [31] . Case 2: Suppose the ordering does not exist. For example, suppose the predictors, x j , x j and x j are equidistant from one another. Clearly, m = 1 may not be a valid assumption and results corresponding to Case 1 become untenable in this situation. For the second order approximation, we start with m = 2, i.e., we would like to obtain the location of the predictors in a compact subset of R 2 . Without loss of generality, we project the locations on unit square ([0, 1] 2 ). Let d jk be the observed distance between the jth and the kth predictor and δ jk be their true, but unobserved, distances. Under the assumption of Euclidean metric,δ jk = ∑ l (s j,l − s k,l ) 2 , where s is now 2D coordinate system denoting the true location of the predictors j and k in unit square. As in Case 1, we can assume that π(.) is the underlying true permutation of 2D configurations of the p predictors. Our goal is to draw inference on the locations of each predictor, i.e. estimate s j .
[32] developed a Bayesian estimation procedure to estimate x(.) based on observed distance by assuming d jk ∼ N(δ jk , σ 2 )I(d jk > 0) at the data level. For the location process, we specify a spatial Homogeneous Poisson Process (HPP) with rate parameter p on unit square, i.e. s s s = {s 1 , s 2 , ..., s p } ∼ HPP(p). Since Poisson process allows at most one event at one location, the HPP specification is essentially a constraint that allows at most one feature to occupy one voxel in the REFINED image. The model is completed by specifying diffuse Inverse Gamma priors on σ 2 . Let us denote the set of observed and true distances by d d d and δ δ δ , respectively. Our data model is then given by
where q=p 2 is the total number of distances in the dataset and Φ(.) is the usual standard normal cdf. At the process level, we have s s s|p ∼ Uni f orm(1/A(s s s))
where A(.) is the area of the compact subset of R 2 where the predictors are projected. Finally, the prior is given by σ 2 ∼ IG(a, b) with a > 2, b > 0 and IG denoting the Inverse Gaussian distribution. Consequently, the full posterior distribution is given by
When q is large, ∑ log Φ(.) ≈ 0, the full conditional posterior of σ 2 |. is approximated by
If the conditional posterior of s s s is not available in closed form, a Metropolis-in-Gibbs sampler is used to obtain posterior realizations of the locations. Since s s s are identifiable only up to an automorphism, convergence of the Markov Chain Monte Carlo (MCMC) is assessed on δ δ δ and σ 2 . Furthermore, following the recommendation of [32] , we used the posterior mode of s s s as the point estimate of the covariate location.
Once these locations are estimated, we have a set of point-reference predictor location in the domain of interest. The domain is then subjected to regular square tessellation such that each voxel contains at most one location (as prescribed by the HPP specification). The foregoing hill climbing algorithm is then applied to arrive at the optimal configuration.
Once the tiled surface associated with the feature space is obtained, we have the observed value, xs j , for each row of X X X. The intensity at each voxel is, therefore, determined by xs j . Voxels that do not contain any feature are assigned null values. Assuming that the intensity at each voxel is constant, we arrive at a discrete random field-a second order approximation of the random functions developed in [31] . We can then deploy any suitable smoothing operation (for example, autoregressive spatial smoothing [33] ) to generate the corresponding predictor images (such as shown in figure 2 ). Furthermore, each posterior realization of s s s can be used for data augmentation purpose in CNN architecture. Also, since Euclidean metric is invariant under translation, rotation and reflection about the origin, any such perturbation will not affect the relationship between the response and predictors.
Note that, even if there exists ordering among the covariates, we can still generate these images in the following way. Since [31] guarantees that the relative pairwise distances among the predictors, estimated from UDS, are consistent estimators of the true relative distances, we can posit a calibration model for these estimatesd jk to connect with the true distance, i.e.d jk ∼ N(α 0 + α 1 δ jk , σ 2 )I(d jk > 0).
Datasets and Preprocessing
To evaluate our framework, we considered four datasets: (a) A synthetically generated dataset (b) NCI 60 dataset consisting of drug responses following application of more than 52,000 unique compounds on 60 human cancer cell lines [22] (c) Genomics of Drug Sensitivity in Cancer (GDSC) [24] dataset that contains responses to 222 anticancer drugs across approximately 972 cancer cell lines with known genomic information. In scenario (b), we use the chemical descriptors of drugs to predict drug responses in a specific cell line. In scenario (c), we consider two heterogeneous predictor set-(i) gene expressions for around cancer cell lines and (ii) chemical descriptors of around drugs and use both these type of predictors to predict drug responses .
(a) Synthetic dataset
We simulated a synthetic dataset with P correlated features for N samples, where for each simulation 20%, 50% and 80% of the features were spurious. The features were simulated from a stationary, isotropic covariance matrix whose (i, j)th element is given by γ |i− j| . We simulated different number of samples for different choices of P. For a given P, we varied N/P ratio according to 0.5, 0.8, 1, 2, 4, 6, 10. For instance, when the number of features is 100 then, 50, 80, 100, 200, 400, 600, 1000 samples were generated using the foregoing covariance matrix. We simulated the target values by simply multiplying random weights to the features. For example, N target values with 100 features (X X X N×100 ), with 20% spurious features were generated using the relation X X X[β β β r , β β β 0 ] T where β β β 80×1 r are non-zero random weights and β β β 20×1 0 are zeros.
(b) NCI dataset
The US National Cancer Institute (NCI) screened more than 52, 000 unique chemicals on around 60 human cancer cell lines. The chemical (drug) response is reported as GI50 which is the concentration required to achieve 50% of maximal inhibition of cell proliferation [22] . All the chemicals have an associated unique NSC identifier number which is assigned to identify agents when they are submitted for clinical trials to the Cancer Therapy Evaluation Program (CTEP). We used the NSC identifiers to obtain the chemical descriptor features and then used PaDEL software [23] to extract these features for each one of the chemicals. The chemicals with more than 10 % of their descriptor values being zero or missing were discarded. The final dataset consists of 52, 126 chemicals, each with 672 descriptor features and 59 cancer cell lines. To incorporate the logarithmic nature of dose ad-ministration protocol, we calculated the negative-log concentration of GI50s (NLOGGI50). The drug response distribution for one illustrative cell lines is shown in figures 3 (a). We selected 17 cell lines with more than 10k drugs, to ensure availability of enough data points for training deep learning models. 
(c) GDSC dataset
For validation of our framework, we also considered the Genomics of Drug Sensitivity in Cancer (GDSC) [24] dataset which describes the responses to 222 anticancer drugs across approximately 972 cancer cell lines. The resulting drug-cell line pairs have the responses reported in the form of IC50 which denotes the concentration of the drug to reduce the response by 50%. The normalized drug response distribution is shown in figure 3(b). We used the gene expression of the cell lines data (17,737 genes), and PaDel descriptors of drug data as predictors. Descriptors with more than 10 % zero or missing values were removed from the dataset, and the rest of missing values were imputed using KNN. Finally, 171K drug-cell line pairs (953 Cell lines, and 206 Drugs) are available for training.
Since in prior drug sensitivity studies [1] [2] [27] , an initial feature selection was used to reduce the number of genes before training the predictive model,we also used an a-priori RELIEFf based feature selection [28] for scenario (c) for easier comparison with earlier studies. Since multiple drugs were tested on each cell line, a common subset of 1211 genes were selected that were found to be common among top 8000 genes selected for each drug. The gene selection process was done on the training set, then the same set of genes were used for validation and test. All the gene expressions and drug descriptors were normalized between 0 and 1.
Predictive Models
We used the REFINED images to train a CNN regressor to predict drug sensitivity of the NCI60, and GDSC datasets, as well as the simulated target values of the synthetic datasets. We compared performance of the REFINED CNN with Random Forest (RF), Support Vector Regressor (SVR), a deep Artificial Neural Network (ANN) for synthetic dataset. For other datasets, along with RF, SVR, and ANN, we compared the REFINED CNN with Elastic Net (EN), CNN with images created by randomly assigning feature coordinates (Random CNN), and CNN with images created using principal component analysis (PCA CNN) coordinates. Random CNN and PCA CNN are detailed in the section 3.1. We picked randomly 17 cell lines where more than 10k drugs were tested on them to have sufficient number of samples to train a deep learning model. Then 17 set of models were trained to predict NLOGGI50 of drugs tested on the selected cell line. In each set, all the abovementioned models were trained on the same set of samples and tested on a separate set of same samples.
Note that for the synthetic dataset and the NCI60 dataset, the predictors are a vector of real values (chemical descriptor values for NCI60) that are converted to images. For the GDSC dataset, we have two types of input features: chemical descriptors describing the drugs and gene expression describing the cell lines. We generated individual images for each feature type and used both of them as inputs to the CNNs. For the RF, SVR, ANN, and EN these two types of features were appended and used as the predictors. We trained REFINED CNN and 6 other competing models on same set of samples, where each sample is a combination of one drug tested on one cell line. All the models were tested on a separate set of similar samples.
The distribution of NLOGGI50 shows a massive point mass at 4 (Figure 3 (a) and (b)) indicating that an overwhelming majority of drugs are not sensitive for majority of the NCI60 cell lines. Thus, we also considered a classification problem of whether a drug is sensitive or resistive among the NCI60 cell lines. Based on the NLOGGI50 distribution for different cell lines, the sensitivity threshold was empirically fixed at 4.5. All the drugs with NLOGGI50 less than the threshold (4.5) were considered resistive and the rest as sensitive. Similar to the regression scenario, we compared the CNN performance with RF, SVM, ANN, logistic regression (LR), Random CNN, and PCA CNN for the classification scenario.
Convolutional Neural Network
Convolutional Neural Networks (CNN) are designed to model multidimensional arrays, where convolutional layers along with pooling layer, are adaptive feature extractors connected to sequential fully connected layers [6] . A convolutional layer consists of multiple kernels connected to a local path of neurons in the previous layer, where all neurons share same parameters to generate a feature map. Thus, all neurons within the feature map scan same features in different locations of the previous layer. The pooling layer summarizes the feature map by finding the maximum/average of each adjacent kernel, which reduces the number of model parameter [5] . We used two different CNN architectures, a sequential CNN for modeling the NCI60 and synthetic dataset, and a hybrid CNN, that can accommodate drug and genetic image, for the GDSC and CCLE datasets.
The sequential CNN regressor contains seven learned layers: one input layer, two convolutional layer, three fully connected layer and one output layer. The CNN input dimension is same as the input image dimension, 26 × 26. The convolutional layer contains 64, 7 × 7 kernels convolving with valid border mode and stride of 2, followed by batch normalization, and ReLu activation. Each fully connected layer is followed by a batch normalization layer and ReLu activation layer. Number of neurons of the fully connected layers are respectively, 512, 256, and 64. A dropout layer with retaining probability of 0.7 was added before the output layer. While the above architecture remains same for Random CNN, PCA CNN and REFINED CNN.
The sequential CNN classifier contains input layer with the same size as the CNN regressor, three convolutional layer with 16 kernels of size 7 × 7, 32 kernels of size 7 × 7, and 64 kernels of size 3 × 3. Each convolutional layer is followed by a batch normalization and ReLu activation layer. The third ReLu layer is followed by two fully connected layers with 256 and 64 neurons respectively. Same as the CNN regressor, each fully connected layer is followed by a batch normalization, ReLu and a drop out layer. The CNN classifier architecture remains same for Random, PCA and REFINED CNN. We used adam optimizer to train both the CNN regressor and classifier.
We used hybrid CNNs with two inputs to model GDSC dataset, where two seperate images are used as inputs of the two arms of the CNN. Each arm containing two convolutional layers were concatenated, and followed by sequential fully connected layers. The two input layers represent the cell lines and drugs images, which defines each convolutional layer dimension. Each arm of CNN used to model GDSC, includes three convolutional layer with 64 kernels with size of 7 × 7, stride of 1, and valid border mode, followed by batch normalization and ReLu activation function layers. Then two convolutional arms of the CNN are concatenated and connected to three sequential fully connected layers with 512,256 and 64 neurons. A bath normalization, ReLu activation function comes after each fully connected layer. A dropout layer with retaining probability of 0.7 comes before output layer. The hybrid CNN was trained by an adam optimizer. The same architecture was utilized for Random, PCA and REFINED images. There are some variation in the architecutre depending on the training set size that are explained in section 3.3.7. All tuning parameters were chosen via nested cross validation
Hyperparameter search
To tune the competitive models we did grid search on the following hyper parameters for each model using nested cross validation:
• RF: Number of decision trees in the forest and number of features evaluated at each node.
• SVM: Gamma parameter of the radial basis function (RBF) kernel.
• EN and LR: Alpha penalty term and L1 ratio.
• ANN: Number of hidden layers (3) (4) (5) (6) , and learning rate of adam optimizer.
• CNN: As we did not have access to GPUs, we did not do comprehensive hyperparameter grid search for the CNNs. The current parameters were chosen over about hundreds of run.
Results
In this section, we report the performance of our REFINED-CNN methodology on the previously described synthetic, NCI60, and GDSC datasets. In each case, the performance of the REFINED CNN was compared to ANN, RF and SVR models. We also compared the REFINED CNN with EN, Random CNN, and PCA CNN for biological datasets. Evaluation Metric: We evaluated the performance of each regression model using (a) normalized root mean square error (NRMSE), (b) Pearsonian correlation (PCC) between the predicted and target values and (c) bias reduction. The NRMSE (4) is the ratio of the root mean squared error (RMSE) of a given model to the RMSE with mean as the predictor. It represents the overall potential of the model to minimize prediction error.
where the y,ȳ , andŷ are respectively the target data, mean of the target values, and predicted target values. We offer NRMSE in order to implicitly compare all the models with respect to the baseline intercept-only model. PCC indicates collinearity between the predicted and observed responses. Lack of collinearity often implies model misspecification and lack of predictive capability.
To represent the bias, we first generated the scatter plot of the residual (ordinate) and the observed response (abscissa). We captured the bias via the angle (θ ) between the best fitted line through the residuals and the abscissa. An unbiased model is expected to produce an angle of 0 • . Therefore, a smaller value of θ indicates that the model is less biased.
We used a standard t-test to report statistical significance in performance across methods. The null hypothesis is if the mean of observed value and predicted values are equal (if the predictive model detected significant portion of the observed values). Therefore, for each model we can test if:
Then the t-test returns a p-value that expresses the probability that this null hypothesis is wrong. Hence, we used t-test to compare the predicted distribution with the observed distribution.
The classification models that predict the sensitive and resistive drugs applied on the NCI60 data cell lines, was evaluated using accuracy, precision, recall, F1 score, and area under the receiver operating characteristic curve (AUROC) metrics. Accuracy is the ratio between correct predictions; true positive (TP) and true negative (TN), over all the predictions; summation of TP, TN, false positive (FP), and false negative (FN).
Precision is the ability of predicting positive instances of the classifiers, or in other words, the ratio of correctly predicted positive instances.
Recall or true positive rate (TPR) is the ability of the classifiers in predicting positive instances, which corresponds to the proportion of of positive instances that are correctly predicted as positive.
Recall = T P T P + FN
F1 score is simply harmonics mean of the precision and recall,
False positive rate (FPR) is a ratio between negative instances that are mistakenly predicted as positive instances. AUROC combines TPR and FPR in many different threshold for each classifier on a single curve, where the area under the curve is considered as AU-ROC.
Comparison with other image generation methods
In this section we consider two image generation methods, random-based and PCA-based, to compare with REFINED. In the random method, we assume each image is a matrix and the location of each entry in the vector is randomly mapped to a location in the matrix. Therefore, we placed each element of the drug descriptors or the gene expression on the image's (matrix) coordinates one after another. Principal component analysis (PCA) [26] is mainly used for dimensionality reduction and visualization purposes, where each sample could be represented on a 2D plane aligned with their principal eigen vectors. On the other way around, if a given matrix of a dataset is transposed, then each feature could be represented by a unique coordinate on a 2D plane. Hence, we transposed the covariates matrix where the rows are features and columns are the samples. Then the first two principal components of the transposed covariates matrix, were selected as the feature's coordinates. Then each feature was mapped on its corresponding coordinates. Some of the generated images using the random and PCA method is shown in figure 2.
Synthetic Data
In this section, we offer the comparative performance of the candidate models on the simulated dataset. First we generate a covariance matrix for P number of features that are highly correlated along side of the diagonal and less correlated towards the off diagonal of the covariance matrix. Then the covariance matrix is utilized to generate N number of samples using the normal distribution. In each case a subset of features were randomly selected as spurious. Then random weights generated for non-spurious feature were used to generate the target values. The generated target values were normalized between 0-1. We have used REFINED to generate images for different N/P scenarios and then trained a CNN for each scenario. In each case, the same dataset was used to train RF, SVR and ANN for comparison. We used five-fold cross validation for all the models on fixed training, validation and test sets. The results are summarized in figure 4 , as heat maps. As shown in figure 4 , the green regions represents the cases where the REFINED-CNN NRMSE is less than the competing models. The heat maps clearly shows, that the REFINED-CNN methodology outperforms others when the number of features are relatively high (> 100) regardless of the percentage of spurious features present in the dataset. We also observe that the performance of the posited methodology improves as the N/P ratio increases. [31] also reported that the performance of their UDS based projection improved with increase in both N and P. Therefore, our findings suggest that our second order REFINED approximation are in agreement with the first order stringing approximation of [31] . Furthermore, we also observe that as the ratio of spurious features increases, the predictive performance of our REFINED-CNN also improves as compared to the competing models. Recall, we are not performing any feature selection for REFINED-CNN for the synthetic data. This exercise demonstrates the ability of our approach to automatically remove spurious features without performing an explicit feature selection a-priori.
We next investigated the effect of the REFINED-CNN approach on the bias characteristics of the prediction. Figure 11 shows the scatter plot of prediction versus actual responses of the four models when 80 % of the features are spurious. Clearly, the scatter plot for REFINED-CNN closely follows a straight line with unit slope indicating predictive accuracy of our approach. RF and SVR reveal their well-known tendency to underpredict higher valued observation and overpredict lower valued observations [17] . REFINED-CNN bias is also better than the bias observed for the ANN scenario. Thus, it appears that the REFINED-CNN approach can automatically improve the prediction bias which some of the other existing models are known to suffer. 
NCI60 dataset

Classification
We investigated the discriminative power of REFINED-CNN as compared to other models in predicting resistant and non-resistant drugs on different cell lines of the NCI60 dataset. The threshold for defining resistant and non-resistant classes, was selected based on the drug response distribution shown in figure 3 . The drugs with NLOGGI50 smaller than 4.25 was considered resistant and the rest as non-resistant. Since, we have sufficiently large number of drugs for each cell line 2 , we randomly considered 80% of the drugs for training, 10% for validation and 10% for testing. As shown in the figure 5 , the REFINED CNN outperforms other classifiers for all 17 cell lines. The average classification accuracy of REFINED-CNN was 75.4% -considerably higher than the average classification accruacy obtained for Random CNN (71.6%), PCA CNN (71.7%), ANN (70.3%), RF (70%), SVM (69%) and LR(67.9%). For each model we report precision, recall, f1-score, and 2 Each unique drug for a particular cell line is sample in this scenario AUROC. REFINED-CNN outperforms other models considering all the metrics. Detailed classification results are provided in appendix tables 4, and 5. The 95 % intervals for each metric per cell lines are provided in table 7 of appendix. Figure 5 : Summary of REFINED-CNN and 6 other competing classifier models performance on randomly selected cell lines of NCI60 database, using the accuracy, precision, recall, f1-score, and AUROC metrics.
To compare significant statistical difference between competing classifiers and RE-FINED CNN we used McNemar's test that is a paired nonparametric statistical hypothesis test. McNemar's test evaluate whether two models disagree in the same way or not. To compare classifiers with REFINED CNN classifier pairwise, a contingency table is formed and McNemar's test is applied [37] . The null hypothesis is whether two classifiers disagree by the same amount. Therefore, if the p-value is smaller than a threshold (0.05), null hypothesis is rejected and the conclusion is: there is a significant disagreement between two classifiers. The results of comparing REFINED CNN with other models using McNemar's test is provided in table 6.
Regression
The NCI60 dataset was randomly partitioned into 80% , 10% , and 10% segments for training, validation and test purpose, respectively. The same training, validation and test set were used for model comparisons. The performance of each model was evaluated using normalized root mean square error (NRMSE), Pearson correlation coefficient (PCC), bias and t-test. Table 8 in the appendix details the performance of each model with respect to the foregoing metrics for different cell lines. The table 8 is summarized in figure 6 , as bar plots. The 95 % interval for all the models per each cell line is provided in table 9 of the appendix. We note that CNN outperforms all the competing models in all 17 cell lines. The average improvement in NRMSE, PCC and bias for REFINED-CNN as compared to other competing models are 6-20%, 8-36 %, and 12-38 %, respectively . 
Data Augmentation
This section analyzes the effect of augmenting the dataset using samples from the less represented regions. As shown in figure 3(a) , the massive point mass associated with the non-sensitive (resistant) drugs severely impacts a global regression model for NLOGGI50. This problem is analogous to zero-inflation problem in classical statistical literature. In such situation, the discrete point mass is modeled separately from the continuous part (see [35, 36] and references therein). In our situation, it boils down to classification into sensitive/resistive category followed by a regression in the sensitive category.
We have already demonstrated superiority of REFINED-CNN in both classification and regression in Tables 4 and 8 , respectively. In this section, we explore if REFINED-CNN's performance could be improved by synthetically oversampling the sensitive category to arrive at a more balanced dataset [34] . To that end, we used a version of SMOTE technique and generated bootstrap replicates from the sensitive category. The NRMSE improvement of REFINED-CNN regression model on different cell lines is illustrated in table 1. The bootstrap data augmentation systematically decreases the NRMSE for the cell lines indicating the negative impact of the point mass in the response distribution. 
Sample Size Analysis
Deep CNN models are expected to perform well with large number of samples and poor with small number of samples. Therefore, we trained our model on different portion of training sets for randomly selected cell lines to test this hypothesis. We trained our model on 20 %, 40 %, 60 % and 80 % of the available drugs applied on the selected cell lines and kept rest of the data for testing, considering NRMSE as comparison metric. The results of five cell lines are summarized in figure 7 which illustrates that REFINED-CNN outperforms the other models as sample size increases. This trend was also observed for the synthetic data ( figure 4 ). 
Model Stacking
To explore whether stacking of multiple models can improve prediction performance, we stacked predicted drug sensitivity of the validation set of all models-in three different combinations-as the covariates in a linear regression model to find the weight of each model which are then employed to predict drug sensitivity of the test set. These three combinations are stacking non-CNN models (RF, SVR, ANN, and EN); stacking CNN models (PCA CNN, Random CNN, and REFINED CNN); and stacking all models (REFINED CNN and 6 other competitors). Figure 8 represents the stacking results where the average NRMSE of stacking all models is 0.738, stacking CNNs is 0.744 and stacking non-CNNs 0.837. By comparing the stacking results, with average NRMSE of each model in table  6 , the stacking produced a significant improvement as compared to non-CNN models individually. It is notable to mention that REFINED CNN average NRMSE in table 6 is significantly lower than stacked of non-CNN models. 
Bias Analysis
In this section, we re-investigate the effect of the REFINED-CNN approach on the bias characteristics of the prediction using actual biological data. Figure 9 shows the plot of the residuals against the observed values. Similar to the earlier presented synthetic data scenario, Figure 9 To investigate whether bias correction erodes the advantage of REFINED-CNN in terms of bias, we considered BC1 bias correction algorithm proposed in [29] where we fit a second model (linear regression was used in this case) on the residuals. The results shown in Figure 9 (b) illustrate the superiority of REFINED-CNN in terms of lowering bias even after bias correction is applied to the competing models.
GDSC dataset
In this section, we consider the application of REFINED CNN that integrates two types of heterogeneous datasets. Our predictors now consist of (a) PaDel chemical descriptors representing the drugs and (b) gene expression profiles for each cell line. The response consists of the experimentally obtained IC50 for each drug-cell line pair. We used the REFINED approach to generate the images corresponding to the gene expressions for each cell line and drug descriptors for each drug compound in the GDSC dataset.
Considering 222 drugs and around 800 cell lines for each drug, the total number of samples in the dataset is close to 177K. We randomly divided the dataset into 90% training, 5% validation and 5% test. Figure 10 presents the scatter plot of the natural log IC50 prediction using our REFINED CNN approach, Random CNN, PCA CNN, ANN, RF, SVR, and EN along with their corresponding residual plots. Table 3 summarizes the performance of each model using NRMSE, PCC, bias, and statistical difference (p-value) metrics. We used t-test to evaluate if the predictive models detect significant portion of the observed values. Hence, large p-values can be interpreted as with high probability the predictive model doesn't capture significant portion of the observed values.
As shown in table 3 , REFINED-CNN model achieves improvement as compared to other models in the range of 1-47% for NRMSE, 1-42%, for PCC. We also train the RE-FINED CNN on 50 % and 10 % of the GDSC data and compared it with other competing models. As the CNN architecture trained on 90 % of the REFINED images was too complex to be trained on 50 % and 10 %, we reduced the network complexity of REFINED CNN and ANN for each training size. At each step we removed one convolutional layer and one fully connected layer from the architecture explained in the section 2.3.1. The detailed corresponding results are provided in the table 10. The predicted and residual scatter plot are provided in the appendix figures 12, 13. 
Discussion
This paper presents a novel approach of converting high dimensional vectors into images with spatial neighborhood dependency that can be used as inputs to traditional Convolutional Neural Networks. The proposed methodology was conceived from the observation that deep learning CNN has increased the prediction accuracy in many scenarios especially when the inputs are images, but it is not usually appropriate when high dimensional vectors with limited neighborhood correlations are used as inputs. Our REFINED approach produces a mapping of the input features such that spatial neighbors are close and far away points in the map are distant in initial feature space.
There are several advantages of the proposed REFINED methodology. First, the RE-FINED mapping to a compact image space appears to allow for automated feature selection using deep learning CNN architecture. Using a synthetic dataset and altering the amount of spurious features, we observed that REFIEND-CNN is able to significantly outperform other approaches for scenarios with larger percentage of spurious features as shown in figure 4. Second, the REFINED CNN approach provides a gain in predictive accuracy as compared to three very commonly used models of Artificial Neural Networks, Random Forest, Support vector Machines, and Elastic Net. We have validated the performance of REFINED-CNN in (a) synthetic dataset, (b) NCI60 drug response dataset and (c) GDSC dataset that combines chemical descriptors of drugs with genomic expressions of cell lines. Third, REFINED-CNN methodology can also be used to seamlessly combine heterogenous predictors where each predictor can be mapped to an image as was done for the GDSC prediction scenario. Perhaps the biggest advantage of REFINED-CNN is that it has the potential to combine multi-type predictors, where some predictors are images, some high dimensional vectors and some having functional forms. In principle, each type of predictor data can be individually mapped to images and the corresponding images can be used as inputs in a CNN architecture. Finally, we observe that REFINED-CNN has better ability to automatically perform bias correction as compared to ANN, RF and SVR as shown in all three application scenarios (Figures 11, 9 and 10) . The proposed REFINED approach can also be used for data augmentation by using different realizations of the mapping as was discussed in section 2.1.1. We have provided a theoretical justification to motivate how the proposed approach can map to an ordering of features if such an ordering exists.
In terms of applications, the REFINED approach can be applied to any predictive modeling scenario where the predictors are high dimensional vectors without an explicit neighborhood based dependence structure. We motivated the application of the scenario through the drug sensitivity prediction problem where both the gene expressions and chemical descriptors are not necessarily ordered based on correlations.
Limitations of the approach will include scenarios where the covariance structure of the features is primarily diagonal with limited correlations between any features. Furthermore, the REFINED approach is expected to benefit from the traditional CNN architecture and thus the performance benefit will require large number of samples as is required for normal CNN scenarios. Also note that, REFINED is a second order approximation under Euclidean norm. If the predictor space is non-Euclidean, the current form of REFINED will not be suitable.
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